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ABSTRACT
Aims In response to the COVID-19 pandemic, the UK 
was placed under strict lockdown measures on 23 
March 2020. The aim of this study was to quantify the 
effects on physical activity (PA) levels using data from the 
prospective Triage- HF Plus Evaluation study.
Methods This study represents a cohort of adult patients 
with implanted cardiac devices capable of measuring 
activity by embedded accelerometery via a remote 
monitoring platform. Activity data were available for the 
4 weeks pre- implementation and post implementation of 
‘stay at home’ lockdown measures in the form of ‘minutes 
active per day’ (min/day).
Results Data were analysed for 311 patients (77.2% 
men, mean age 68.8, frailty 55.9%. 92.2% established 
heart failure (HF) diagnosis, of these 51.2% New York 
Heart Association II), with comorbidities representative of a 
real- world cohort.
Post- lockdown, a significant reduction in median PA 
equating to 20.8 active min/day was seen. The reduction 
was uniform with a slightly more pronounced drop in PA 
for women, but no statistically significant difference with 
respect to age, body mass index, frailty or device type. 
Activity dropped in the immediate 2- week period post- 
lockdown, but steadily returned thereafter. Median activity 
week 4 weeks post- lockdown remained significantly lower 
than 4 weeks pre- lockdown (p≤0.001).
Conclusions In a population of predominantly HF patients 
with cardiac devices, activity reduced by approximately 
20 min active per day in the immediate aftermath of strict 
COVID-19 lockdown measures.
Trial registration number NCT04177199.
BACKGROUND
The COVID-19 pandemic brought restric-
tions on the daily lives of the global popu-
lation. For at least the initial phase, the UK 
population was advised to isolate at home, 
an unprecedented public health message. 
Although survey data suggest a mixed 
response by the general population,1 2 the 
effect of the ‘lockdown’ instruction on 
physical activity (PA) has yet to be objec-
tively quantified. Focusing on people living 
with heart failure (HF), given contempo-
rary health advice for managing stable HF 
in the community typically includes regular 
PA as part of a healthy lifestyle,3 any signif-
icant drop may have negative health conse-
quences for these patients.
Modern cardiac implantable electronic 
devices (CIEDs) have multiple built in 
sensors which allow them to monitor a 
wide range of physiological parameters, 
including PA levels, continuously and auto-
matically. When paired with home moni-
toring, these data can be monitored by 
clinical teams.4
AIMS
Using activity data collected from CIEDs 4 
weeks before and after the imposition of 
strict COVID-19 lockdown measures as part 
of the ongoing prospective Triage- HF Plus 
Key questions
What is already known about this subject?
 ► The impact of initial strict lockdown measures im-
plemented during the COVID-19 pandemic on daily 
physical activity (PA) remains poorly understood. 
Survey data suggest a mixed response by the pop-
ulation, however self- reported PA can be unreliable.
What does this study add?
 ► This study takes advantage of objective remote 
monitoring data from implanted cardiac devices for 
a cohort of cardiac patients enrolled in a prospective 
cohort study. PA data were shown to drop by ap-
proximately 20 min/day across the cohort studied, 
although weekly trends suggest activity levels were 
returning to baseline by 3–4 weeks post- lockdown 
implementation.
How might this impact on clinical practice?
 ► Regular PA is integral for the maintenance of health 
and well- being, particularly for those with chron-
ic diseases such as heart failure, and age- related 
physical frailty. Clinicians should consider the im-
pact of reduced activity on their patient cohort when 
providing advice and delivering services for chronic 
disease groups during the pandemic.
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Evaluation (Triage- HF Plus), we aim to quantify behav-
ioural changes in activity in a cohort of CIED patients 
with HF.
METHODS
The Triage- HF Plus study is a prospective observa-
tional study involving three hospital sites in North West 
England, UK. Briefly, Triage- HF Plus is a telephone- based 
clinical care pathway which uses remote monitoring data 
from CIEDs (Medtronic Triage Heart Failure Risk Status 
(HFRS)) to identify patients at increased risk of decom-
pensated HF.5 The aim of the study is to evaluate work-
force burden and healthcare utilisation associated with 
the pathway. Recruitment began on 6 September 2019 
and remains ongoing. Inclusion criteria include: over 18 
years, HFRS compatible CIED in situ, able to comply with 
remote monitoring and follow- up.
Daily activity data are collected as part of the HFRS, 
measured by an accelerometer within the CIED, and 
stored as time ‘active’ per day based on an accelerometer 
count threshold.6 7 For this evaluation, activity data were 
available as ‘total minutes active per week’. We extracted 
data for the 4 weeks preceding and following the formal 
announcement of strict national lockdown measures in 
England on the evening of 23 March 2020. Prior to this 
announcement, life continued largely as normal until 
16 March when the prime minister announced advice 
to ‘stop non- essential contact with others and to stop all 
unnecessary travel’,8 however, due to ‘panic buying’ and 
uncertainty, it is generally accepted that strict ‘lockdown’ 
started in the UK after 23 March. In England, govern-
ment guidance was to remain at home unless required 
to go outdoors for a list of very limited reasons (essential 
work, shopping for necessities as infrequently as possible, 
medical or care reasons, or a short (maximum 60 min) 
daily period of exercise).9 10 This advice did not signifi-
cantly change in the 4 weeks following the announcement.
Analysis was performed on Microsoft Excel 2019 and R 
software (V.4.0.2, 2020). Only participants with complete 
activity data for all 8 weeks studied were included. 
Statistical tests employed include paired t- test, paired 
Wilcoxon- test, Welsh two sample t- test (when Bartlett test 
significant for homogeneity of variance), analysis of cova-
riance (ANCOVA) for multiple categorical variables, and 
Pearson/Spearman’s rank correlation (for continuous 
variables). A p value <0.05 was considered significant, 
where MD denotes difference in means.
RESULTS
At the time of data retrieval, demographic and clinical 
data were available for 414 patients, of which 8 weeks 
of complete activity data were available for 311 patients 
(75.1%). An overview of the studied population is shown 
in table 1.
Of note, the majority of the studied population (77.2%) 
were men, with 56% over 70 years of age. Most had a high 
body mass index (BMI) (77% over 25). Two hundred 
Table 1 Demographics table
Demographics n (%)
Hospital sites Manchester Heart 
Centre
117 (37.6)




















White British 259 (83.8)





Index of multiple deprivation 
decile*
Missing data n=10
Median decile 4 (range 1–10)
Device type
Missing data n=1
CRT ICD 204 (65.8)




Current smoker 30 (9.8)
Former smoker 154 (50.2)















Yes, current depression 38 (12.5)
Yes, previous depression 33 (10.9)
CKD 3 or greater
Missing data n=12









Previous, ablated 5 (1.6)
Continued
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and eighty- three (92.2%) patients had established HF, 
with 52.2% NYHA (New York Heart Association) class 
II. The majority were fitted with a cardiac resynchroni-
sation device with defibrillator. Comorbidities included: 
diabetes (73.3%), ischaemic heart disease (52.1%), 
hypertension (45.6%), atrial fibrillation (44.6%), chronic 
kidney disease (42.1%) and frailty (55.9%, defined as a 
PRISMA-7 score ≥3).11
79.1% (246) of the cohort had a reduction in activity 
post- lockdown. Median activity per day in the 4 weeks 
pre- lockdown was 134.7 min/day (min/day) compared 
with 113.9 min/day in the 4 weeks post- lockdown. Post- 
lockdown there was a significant reduction in activity 
(p<0.001), equating to a reduction of 20.8 active min/
day.
This reduction was uniform across the cohort (as 
demonstrated in figures 1 and 2), with subgroup analyses 
demonstrating a small but significantly more pronounced 
drop in activity for females (MD=6.2, 95% CI 0.1 to 12.3, 
p=0.04), but no statistically significant difference with 
respect to age (Spearman’s r=0.03, p=0.57), BMI (Spear-
man’s r=−0.09, p=0.11), frailty (MD=0.9, 95% CI −4.4 to 
6.3, p=0.7), or device type (MD=5.5, 95% CI −13.1 to 2.1, 
p=0.16). A consistent pattern of activity across the 8 weeks 
studied emerged (see figure 1). PA was largely static 
leading up to lockdown implementation, followed by a 
precipitous drop in the 2 weeks post- lockdown. In the 
third and fourth week post- lockdown, there was a steady 
increase in observed activity, but this did not generally 
return to pre- lockdown levels (median activity week-1 
138.6 min/day vs mean activity week-8 118.9 min/day, 
p≤0.001).
An exploratory analysis of the 65 (20.9%) patients 
whose total activity levels did not decrease post- lockdown 
found there was no significant difference in pre- lockdown 
activity (3839 median min active vs 3839.0 min active, 
p=0.62), or proportion of patients in the first or last 
quartile of pre- lockdown activity (first 29.2% vs 24.0%, 
last 27.7% vs 24.0%, p=0.48). There was no significant 
difference in demographics or comorbidities (as listed in 













PRISMA 7 score ≥3
174 (55.9)
*Where 1=most deprived area, 10=least deprived area.
†For patients with HF only.
BMI, body mass index; CKD, chronic kidney disease; CRT, 
cardiac resynchronisation therapy device; EF, ejection fraction; 
HF, heart failure; HFPEF, HF with preserved ejection fraction; 
HFREF, HF with reduced ejection fraction; ICD, implanted 
cardiac defibrillator; NYHA, New York Heart Association; PPM, 
pacemaker.
Table 1 Continued
Figure 1 Physical activity pre- first and post- first UK 
lockdown by age, gender and BMI. Note only 16 participants 
with BMI <18.5 which may explain marked deviation in PA 
from other BMI groups. BMI, body mass index; PA, physical 
activity.
Figure 2 Physical activity pre- first and post- first UK 
lockdown by frailty, IMD, NYHA and device type. Note 
NYHA class IV not included as n=1. IMD, index of multiple 
deprivation; NYHA, New York Heart Association Functional 
Classification; PA, physical activity.
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CONCLUSION
This is the first study quantifying the behavioural effects 
of the public health lockdown instructions using a study 
cohort of HF CIED patients undergoing objective daily 
activity monitoring as part of clinical remote monitoring. 
Our results show that activity dropped significantly 
during lockdown across all groups by approximately 20 
min/day, with a trend to return to prior levels of activity 
by week three/four post initial lockdown measures. 
Twenty per cent of the cohort did not reduce their levels 
of activity. Exploratory analysis of this subgroup did not 
reveal any clear distinguishing characteristics, and similar 
NYHA score, frailty and pre- lockdown activity levels 
would suggest these are patients with matched functional 
status. Longer follow- up is required to establish if this is a 
sustained picture.
While other studies have reported reduced PA levels 
associated with global lockdown (by way of survey, mobile 
phone data and wearable devices12–15) this is the first 
report using a Medicines and Healthcare products Regu-
latory Agency/European Medicines Agency approved 
implanted device in an HF population. Furthermore, the 
demographic data recorded as part of this clinical study 
allows us examine the impact of key clinical characteris-
tics on activity—a limitation of previous reports on lock-
down activity.
This study demonstrates a rapid, quantifiable, nega-
tive effect on PA regardless of age, gender, BMI or 
frailty status—something perhaps never seen before in 
this generation. Further follow- up is required to estab-
lish if this change is sustained, or whether patients will 
adapt to keep active by other means or return to prior 
levels of activity in the long- term. Multiple studies have 
demonstrated a positive correlation between activity and 
overall health, and particularly for an older population 
with HF and/or frailty.16–18 Even short periods of seden-
tary behaviour can result in muscle wasting and func-
tional decline.19 The long- term consequences of reduced 
activity in this population is unclear. As we prepare for a 
second, and possibly recurrent waves of infection in the 
absence of an effective vaccine, the risk/benefit discussion 
surrounding stringent lockdown and shielding measures 
for high- risk groups should consider these implications 
which may be possible to mitigate with regular exercise 
programmes, for example.
This study was limited to a predetermined cohort 
with data for the 4 weeks before and after lockdown 
making it difficult to extrapolate and predict the long- 
standing, clinically relevant adverse effect of this reduc-
tion in activity. The way in which activity is captured by 
the device is limited in two major ways: first PA below the 
device threshold would not be stored by the device, and 
second static exercise (such as an exercise bike) would 
not reliably trigger the accelerometer. Although evidence 
suggests device accelerometery strongly correlates with 
activity as measured by external monitors for the majority 
of HF patients,20 these limitations are pertinent when 
considering patients may switch to home gym equipment 
in response to the restrictions.
Finally, the study participants of the Triage- HF Plus 
study were largely of white British ethnicity (83.8%). The 
generalisability of our results to the UK broader popu-
lation is of interest, but beyond the scope of this report.
In conclusion, in a UK population of HF patients with 
compatible cardiac devices undergoing remote moni-
toring, PA reduced by approximately 20 min/day in 
the immediate aftermath of strict COVID-19 lockdown 
measures.
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